Letter: the effect of sirolimus on recurrence and survival in liver transplant recipients with hepatocellular carcinoma
Open Access
- 28 November 2018
- journal article
- letter
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 48 (11-12) , 1330-1331
Abstract
Linked ContentThis article is linked to Menon et al papers. To view these articles visit https://doi.org/10.1111/apt.12185 and https://doi.org/10.1111/apt.15038.Keywords
This publication has 6 references indexed in Scilit:
- International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant RecipientsTransplantation, 2018
- Sirolimus in Liver Transplant Recipients with Hepatocellular Carcinoma: An Updated Meta-AnalysisJournal of Investigative Surgery, 2018
- Meta‐analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinomaAlimentary Pharmacology & Therapeutics, 2012
- Impact of Sirolimus on the Recurrence of Hepatocellular Carcinoma After Liver TransplantationLiver Transplantation, 2009
- Introduction to Meta‐Analysis2009
- Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinomaLiver Transplantation, 2008